Clover Health Investments Quarterly Income Statement
NASDAQ: CLOVHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Clover Health Investments revenue and earnings
In the quarter ended Sep 30, 2026, Clover Health Investments generated $759.3 million in revenue, up 52.9% from the same quarter a year earlier. Net income was $6.4 million, for a net margin of 0.8% versus a median of -2.2% in the prior 5 quarters. Operating margin was 0.8%.
Diluted earnings per share came in at $0.01.
Summary generated from market data by MetaCap's automated system. Methodology
Clover Health Investments income statement (quarterly)
| Quarter (USD) | Q3 20262026-09-30 | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 759.30M | 743.17M | 749.19M | 487.71M | 496.65M | 477.62M | 462.33M | 336.96M | 330.99M | 356.26M | 346.92M | 312.38M |
| Revenue growth (YoY) | +52.89% | +55.60% | +62.05% | +44.74% | +50.05% | +34.07% | +33.27% | +7.87% | +8.16% | +11.28% | +7.74% | — |
| Gross Profit | — | — | — | — | — | — | — | — | 81.21M | 107.91M | 81.76M | 64.01M |
| Operating Expenses | 752.87M | 715.17M | 721.86M | 537.03M | 521.03M | 488.18M | 463.61M | 358.41M | 339.77M | 349.07M | 369.63M | 375.52M |
| Operating Income | 6.43M | 28.00M | 27.33M | -49.32M | -24.38M | -10.56M | -1.27M | -21.45M | -8.79M | 7.19M | -22.70M | -63.13M |
| Interest Expense | — | — | — | — | — | — | — | 0 | 0 | 0 | — | 0 |
| Net Income | 6.43M | 28.00M | 27.33M | -49.32M | -24.38M | -10.58M | -1.27M | -22.09M | -9.15M | 7.41M | -19.17M | -70.47M |
| Net Income growth (YoY) | — | — | — | — | — | -242.79% | — | — | — | — | — | — |
| EPS (Basic) | 0.01 | 0.05 | 0.05 | -0.10 | -0.05 | -0.02 | 0.00 | -0.03 | -0.02 | 0.01 | -0.05 | -0.14 |
| EPS (Diluted) | 0.01 | 0.05 | 0.05 | -0.10 | -0.05 | -0.02 | 0.00 | -0.03 | -0.02 | 0.01 | -0.05 | -0.14 |
| Shares Outstanding (Basic) | 531.60M | 524.19M | 522.18M | — | 512.74M | 509.04M | 497.06M | — | 490.18M | 487.48M | 486.37M | — |
| Shares Outstanding (Diluted) | 557.48M | 545.45M | 532.50M | — | 512.74M | 509.04M | 497.06M | — | 490.18M | 495.18M | 486.37M | — |
| EBITDA | 5.99M | 27.57M | 26.89M | -49.82M | -24.77M | -11.07M | -1.71M | -21.83M | -9.31M | 6.24M | -23.37M | -64.05M |
| Gross Margin | — | — | — | — | — | — | — | — | 24.54% | 30.29% | 23.57% | 20.49% |
| Operating Margin | 85.00% | 3.77% | 3.65% | -10.11% | -4.91% | -2.21% | -28.00% | -6.37% | -2.65% | 2.02% | -6.54% | -20.21% |
| Net Margin | 85.00% | 3.77% | 3.65% | -10.11% | -4.91% | -2.21% | -28.00% | -6.56% | -2.77% | 2.08% | -5.53% | -22.56% |
This table shows 12 quarterly periods of Clover Health Investments's income statement, from Q3 2026 back to Q4 2023, across 14 line items including revenue, gross profit, operating expenses. Values in USD; B = billions, M = millions. Fiscal periods follow CLOV's reporting calendar. What is a income statement?